This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Intervet International B.v., Universitât Bern, University of Bern. Active years: 2010-2014.
Location History:
- Urtenen-Schönbühl, CH (2010)
- Bern, CH (2014)
Company Filing History:
1 out of 107 
1 out of 67 
1 out of 26 Years Active: 2010-2014
Title: Edy M Vilei: Innovator in Toxin Research and Vaccine Development
Introduction
Edy M Vilei is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of microbiology, particularly in the identification of novel toxins and the development of vaccines. With a total of 2 patents, Vilei's work has implications for both scientific research and public health.
Latest Patents
Edy M Vilei's latest patents include groundbreaking inventions. One patent pertains to the identification and initial characterization of CctA, a novel secreted toxin that represents major cytotoxic activity. This toxin exhibits strong hemolytic activity towards erythrocytes of various species, and anti-CctA antibodies can fully neutralize hemolysis on standard blood-agar medium or in cell-free supernatants of liquid cultures. Another patent focuses on a mycoplasma subunit vaccine, which relates to vaccines for combating infections. This invention includes mycoplasmal L-α-glycerophosphate oxidase for use in such vaccines, methods for their preparation, and diagnostic tests to differentiate vaccinated animals from those suffering from field infections.
Career Highlights
Edy M Vilei has had a distinguished career, working with reputable institutions such as the University of Bern and Intervet International B.V. His research has contributed to advancements in vaccine technology and toxin characterization, making him a respected figure in his field.
Collaborations
Throughout his career, Vilei has collaborated with notable colleagues, including Joachim Frey and Paola Pilo. These partnerships have enhanced his research and contributed to the success of his inventions.
Conclusion
Edy M Vilei's innovative work in toxin research and vaccine development highlights his significant contributions to science and public health. His patents reflect a commitment to advancing knowledge and improving health outcomes.